Vanta Bioscience Ltd
BSE: 540729
values in crores
Revenue & Profit Trend
in croresRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q4 FY25 | Q2 FY25 | Q4 FY24 | Q2 FY24 |
|---|---|---|---|---|---|
| INCOME | |||||
| Revenue | 0.30-7.4% | 0.33-59.3% | 0.80-75.9% | 3.33-36.4% | 5.23 |
| Other Income | — | 0.04 | — | 0.05 | — |
| Total Income | 0.30-17.3% | 0.36-54.4% | 0.80-76.3% | 3.37-35.5% | 5.23 |
| EXPENSES | |||||
| Expenditure | 2.16+22.7% | 1.76-17.0% | 2.12-39.0% | 3.48-31.5% | 5.08 |
| Tax | 0.05+56.7% | 0.03+0.0% | 0.03-14.3% | 0.04+34.6% | 0.03 |
| PROFIT | |||||
| PBT | -1.86-33.2% | -1.40-5.6% | -1.32-1125.0% | -0.11-172.0% | 0.15 |
| Net Profit | -1.81-27.0% | -1.43-10.4% | -1.29-1671.2% | -0.07-158.4% | 0.13 |
| KEY METRICS | |||||
| OPM % | — | -100.00% | — | -56.55% | — |
| NPM % | -100.00% | -100.00% | -100.00%-97.84pp | -2.16%-4.55pp | 2.39% |
| EPS | -2.55-18.1% | -2.16-5.4% | -2.05-1608.3% | -0.12-160.0% | 0.20 |
Corporate Events
Board MeetingVANTABIO
202613Nov
Board Meeting
The meeting of the Board of Directors of the Company is sche…
BSE Filing ↗ Board MeetingVANTABIO
202630Sep
Board Meeting
The 10th Annual General Meeting (AGM) of the Company will be…
BSE Filing ↗ Board MeetingVANTABIO
20265Sep
Board Meeting
The Board of Directors considered and approved the Annual Re…
BSE Filing ↗ Board MeetingVANTABIO
202630May
Board Meeting
The board meeting is scheduled to consider and approve the S…
BSE Filing ↗ Board MeetingVANTABIO
202530May
Board Meeting
consider and approve the Standalone and Consolidated financi…
BSE Filing ↗ Board MeetingVANTABIO
202414Nov
Board Meeting
Consider and approve un-audited financial results, take note…
BSE Filing ↗ Board MeetingVANTABIO
202419Jul
Board Meeting
consider and approve the Standalone and Consolidated financi…
BSE Filing ↗ Board MeetingVANTABIO
202417Jul
Board Meeting
Consider and approve the standalone and consolidated audited…
BSE Filing ↗